Dr. Geoffrey Shouse is an Assistant Professor in the Department of Hematology & Hematopoietic Cell Transplantation at City of Hope in Duarte, California. He earned his PhD in Cell, Molecular and Developmental Biology from the University of California, Riverside, and his Doctor of Osteopathic Medicine degree from Western University of Health Sciences in Pomona, California. He completed his residency in Internal Medicine and his fellowship in Hematology and Medical Oncology at Loma Linda University Medical Center in Loma Linda, California. He then completed a fellowship in Stem Cell Transplant and Cellular Therapy at City of Hope in Duarte, California. He is board-certified in Internal Medicine, Medical Oncology, and Hematology by the American Board of Internal Medicine.
Dr. Shouse specializes in lymphoid malignancies, including diffuse large B-cell lymphoma, follicular lymphoma, mantle cell lymphoma, chronic lymphocytic leukemia, and Waldenström macroglobulinemia. His clinical and research work focuses on CAR T-cell therapy, bispecific antibodies, treatment sequencing, and personalized approaches for patients with relapsed or refractory disease. He also studies aging, frailty, and functional outcomes among older adults receiving CAR T-cell therapy and other intensive treatments. His work has been recognized with awards including the American Society of Hematology Abstract Achievement Award and research and poster presentation awards during his training.
Dr. Shouse’s professional interests include cellular immunotherapy, lymphoma research, clinical trials, and education on emerging therapies. He is engaged in clinical research and educational initiatives that help oncology teams identify appropriate patients, coordinate referrals, and navigate treatment considerations.